Details for 2012795842
Up to date per 03.04.2026
Actions
Details for 2012795842
Granted/Registered
European Patent
08.10.2014 A
16.10.2019 B1
30.11.2011
US
201161564975 P
A61K 31/519 20060101AFI20181122BHEP
Owner
Astrazeneca AB 151 85 SödertäljeSE
Representative
Representative
Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT
Inventor
DAVIES, Barry, RobertAstraZeneca R&D Alderley Alderley Park Macclesfield Cheshire SK10 4TGGB
Information about Fees